妊娠期感染COVID-19母亲所生婴儿的新生儿听力筛查结果:一项回顾性队列研究
该回顾性病例对照研究比较了458例妊娠期COVID-19感染母亲与339例疫情前分娩母亲的新生儿听力筛查结果。第二次筛查未通过率在COVID-19组为1.3%,对照组为2.9%,两组最终筛查结果无显著差异。结论认为妊娠期COVID-19感染不是听力损失的危险因素。
要点
- 妊娠期COVID-19感染母亲的新生儿第二次听力筛查未通过率为1.3%。
- 对照组第二次听力筛查未通过率为2.9%,两组无显著差异。
- 妊娠期COVID-19感染不是新生儿听力损失的危险因素。
核心结论
- 根据新生儿听力筛查结果,妊娠期COVID-19感染未被发现是听力损失的危险因素。
研究设计与样本
- 回顾性病例对照研究,纳入458例妊娠期有COVID-19感染史的妇女与339例疫情前分娩的妇女。
- 感染组为在三级大流行医院急诊COVID-19门诊就诊且逆转录聚合酶链反应(RT-PCR)检测确诊感染的孕妇。
- 排除出生时<34周的新生儿及数据库中报告有先天畸形或已知妊娠期TORCH感染等危险因素者。
- 筛查采用自动听性脑干反应或瞬态诱发耳声发射(TEOAE),首次筛查未通过者至少间隔2周进行第二次筛查。
主要发现
- 第二次筛查未通过率在COVID-19组为1.3%,对照组为2.9%,两组最终筛查结果无显著差异。
- 458例母亲中,8例在妊娠早期感染,126例在妊娠中期感染,127例在妊娠晚期感染但感染后15天内未分娩,197例分娩时阳性。
- 感染组有6例新生儿第二次筛查未通过(妊娠中期感染3例[2.4%],妊娠晚期感染1例[0.8%],分娩时阳性2例[1.0%])。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Viral infections are known to be a risk factor for neonatal hearing loss. COVID-19 infection has been reported to affect hearing test results in one small sample sized study. We aimed to investigate the incidence the risk of neonatal hearing loss in infants of mothers who had COVID-19 infection during pregnancy, regarding their trimesters, by evaluating the neonatal hearing screening results. DESIGN: In this retrospective case-control study, neonatal hearing test results of 458 women with a history of COVID-19 infection in pregnancy were compared with 339 women who gave birth before the pandemic. Data of pregnant women who attended the COVID-19 outpatient clinic of the emergency service of a tertiary pandemic hospital and who had confirmed infection with a reverse transcriptase-polymerase chain reaction (RT-PCR) test were determined from the hospital's records and their neonatal hearing screening results were analyzed from the national database. Neonates born before <34 weeks, and with reported risk factors in the database such as congenital anomaly or known TORCH infection during pregnancy were excluded. The screening tests, Automated Auditory Brainstem Response or Transient Evoked Otoacoustic Emission (TEOAE), were used for screening, and patients who failed the first screening were reevaluated at least 2 weeks apart with a second screening. RESULTS: The incidence of failed second screening was 1.3% in the COVID-19 group and 2.9% in controls, and no significant difference was observed between the two groups according to the final screening results on the second test. Among the 458 mothers, 8 were infected in first trimester, 126 in second trimester, 127 in third trimester but did not deliver within 15 days after infection and 197 were positive at birth. Six neonates in the infected group failed the second screening (3 [2.4%] in the second trimester, 1 [0.8%] third trimester, and 2 [1.0%] positive at birth). CONCLUSIONS: COVID-19 infection during pregnancy was not found to be a risk factor for hearing loss, according to the newborn hearing screening results.
引用
- Oskovi-Kaplan ZA, Ozgu-Erdinc AS, Buyuk GN, et al. Newborn Hearing Screening Results of Infants Born To Mothers Who Had COVID-19 Disease During Pregnancy: A Retrospective Cohort Study. Ear Hear. 2022. PMID: 34812792. doi:10.1097/AUD.0000000000001167
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。